Kodiak Sciences Inc. (KOD)
NASDAQ: KOD · Real-Time Price · USD
36.23
-1.18 (-3.15%)
At close: May 22, 2026, 4:00 PM EDT
35.93
-0.30 (-0.83%)
After-hours: May 22, 2026, 4:15 PM EDT
Kodiak Sciences Market Cap
Kodiak Sciences has a market cap or net worth of $2.26 billion as of May 22, 2026. Its market cap has increased by 1,009.20% in one year.
Market Cap
2.26B
Enterprise Value
2.15B
1-Year Change
1,009.20%
Ranking
Category
Stock Price
$36.23
Market Cap Chart
Since October 4, 2018, Kodiak Sciences's market cap has increased from $357.63M to $2.26B, an increase of 531.85%. That is a compound annual growth rate of 27.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 21, 2026 | 2.34B | 34.81% |
| Dec 31, 2025 | 1.73B | 231.69% |
| Dec 31, 2024 | 522.39M | 228.65% |
| Dec 29, 2023 | 158.95M | -57.33% |
| Dec 30, 2022 | 372.50M | -91.44% |
| Dec 31, 2021 | 4.35B | -41.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 4, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vera Therapeutics | 2.48B |
| Relay Therapeutics | 2.46B |
| Celldex Therapeutics | 2.40B |
| Nektar Therapeutics | 2.33B |
| Immunome | 2.32B |
| Definium Therapeutics | 2.29B |
| Ultragenyx Pharmaceutical | 2.26B |
| Mineralys Therapeutics | 2.25B |